Showing results (71-80 of 147) with videos related to
Sort By:
Pageof 15
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 14, 2026
Association of platinum-based chemotherapy with survival in ovarian carcinosarcoma: a retrospective 2-center cohort studyYasmin Abozenah, Hadi Erfani, Carolyn Haunschild, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibodyChristine E Richter, Emiliano Cocco, Stefania Bellone, et al.Clinical & Experimental Metastasis|September 6, 2013
Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxelDana M Roque, Natalia Buza, Michelle Glasgow, et al.Medical Oncology (Northwood, London, England)|April 12, 2017
Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivoGulden Menderes, Elena Bonazzoli, Stefania Bellone, et al.Cancer|April 16, 2013
Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilonesDana M Roque, Stefania Bellone, Diana P English, et al.BJC Reports|November 8, 2024
Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer (NCT03093155): Updated survival and subgroup analysesDana M Roque, Eric R Siegel, Natalia Buza, et al.Journal of Gynecologic Oncology|August 25, 2021
Financial toxicity in patients with gynecologic malignancies: a cross sectional studyBurak Zeybek, Emily Webster, Natalia Pogosian, et al.Gynecologic Oncology|May 2, 2015
Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patientsStefania Bellone, Floriana Centritto, Jonathan Black, et al.Cancer|June 22, 2011
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxinFrancesca Casagrande, Emiliano Cocco, Stefania Bellone, et al.American Journal of Obstetrics and Gynecology|August 15, 2015
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitroStefania Bellone, Jonathan Black, Diana P English, et al.Pageof 15